The Greenrose Holding Company Inc.
The Greenrose Holding Company Inc. (GNRSU) Stock Competitors & Peer Comparison
See (GNRSU) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GNRSU | $0.00 | -100.00% | 13 | 0.00 | $3.10 | N/A |
| IPSEY | $48.01 | -1.12% | 63.5B | 30.77 | $1.56 | +0.83% |
| MKGAF | $131.98 | +0.94% | 59.1B | 18.76 | $7.25 | +1.95% |
| MKKGY | $26.33 | +0.85% | 56.9B | 18.55 | $1.41 | +1.91% |
| TKPHF | $33.13 | -4.03% | 52.3B | 73.62 | $0.45 | +3.93% |
| HLNCF | $4.95 | +8.79% | 44.1B | 19.80 | $0.25 | +1.94% |
| SDZNY | $80.93 | -0.48% | 35B | 38.72 | $2.09 | +0.76% |
| TEVJF | $28.36 | +0.00% | 33B | 23.44 | $1.21 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
GNRSU vs IPSEY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, IPSEY has a market cap of 63.5B. Regarding current trading prices, GNRSU is priced at $0.00, while IPSEY trades at $48.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas IPSEY's P/E ratio is 30.77. In terms of profitability, GNRSU's ROE is +0.15%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, GNRSU is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check IPSEY's competition here
GNRSU vs MKGAF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, MKGAF has a market cap of 59.1B. Regarding current trading prices, GNRSU is priced at $0.00, while MKGAF trades at $131.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas MKGAF's P/E ratio is 18.76. In terms of profitability, GNRSU's ROE is +0.15%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, GNRSU is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check MKGAF's competition here
GNRSU vs MKKGY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, MKKGY has a market cap of 56.9B. Regarding current trading prices, GNRSU is priced at $0.00, while MKKGY trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas MKKGY's P/E ratio is 18.55. In terms of profitability, GNRSU's ROE is +0.15%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, GNRSU is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check MKKGY's competition here
GNRSU vs TKPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TKPHF has a market cap of 52.3B. Regarding current trading prices, GNRSU is priced at $0.00, while TKPHF trades at $33.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TKPHF's P/E ratio is 73.62. In terms of profitability, GNRSU's ROE is +0.15%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, GNRSU and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
GNRSU vs HLNCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HLNCF has a market cap of 44.1B. Regarding current trading prices, GNRSU is priced at $0.00, while HLNCF trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HLNCF's P/E ratio is 19.80. In terms of profitability, GNRSU's ROE is +0.15%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, GNRSU is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HLNCF's competition here
GNRSU vs SDZNY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SDZNY has a market cap of 35B. Regarding current trading prices, GNRSU is priced at $0.00, while SDZNY trades at $80.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SDZNY's P/E ratio is 38.72. In terms of profitability, GNRSU's ROE is +0.15%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, GNRSU is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SDZNY's competition here
GNRSU vs TEVJF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TEVJF has a market cap of 33B. Regarding current trading prices, GNRSU is priced at $0.00, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, GNRSU's ROE is +0.15%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, GNRSU and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
GNRSU vs TAIPY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, GNRSU is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, GNRSU's ROE is +0.15%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, GNRSU is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check TAIPY's competition here
GNRSU vs ESALY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GNRSU is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GNRSU's ROE is +0.15%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GNRSU is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ESALY's competition here
GNRSU vs SGIOY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SGIOY has a market cap of 16.6B. Regarding current trading prices, GNRSU is priced at $0.00, while SGIOY trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SGIOY's P/E ratio is 15.46. In terms of profitability, GNRSU's ROE is +0.15%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, GNRSU is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SGIOY's competition here
GNRSU vs SGIOF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SGIOF has a market cap of 16.3B. Regarding current trading prices, GNRSU is priced at $0.00, while SGIOF trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SGIOF's P/E ratio is 15.16. In terms of profitability, GNRSU's ROE is +0.15%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, GNRSU is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SGIOF's competition here
GNRSU vs BIOVF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, GNRSU is priced at $0.00, while BIOVF trades at $39.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas BIOVF's P/E ratio is 265.80. In terms of profitability, GNRSU's ROE is +0.15%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, GNRSU is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check BIOVF's competition here
GNRSU vs IPSEF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, GNRSU is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, GNRSU's ROE is +0.15%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, GNRSU is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check IPSEF's competition here
GNRSU vs ESALF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, GNRSU is priced at $0.00, while ESALF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ESALF's P/E ratio is 27.27. In terms of profitability, GNRSU's ROE is +0.15%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, GNRSU is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ESALF's competition here
GNRSU vs ESAIY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ESAIY has a market cap of 8.4B. Regarding current trading prices, GNRSU is priced at $0.00, while ESAIY trades at $7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ESAIY's P/E ratio is 26.21. In terms of profitability, GNRSU's ROE is +0.15%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, GNRSU is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ESAIY's competition here
GNRSU vs SFOSF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, GNRSU is priced at $0.00, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, GNRSU's ROE is +0.15%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, GNRSU is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SFOSF's competition here
GNRSU vs GZPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, GNRSU is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, GNRSU and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
GNRSU vs LVZPF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, GNRSU is priced at $0.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, GNRSU's ROE is +0.15%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, GNRSU is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check LVZPF's competition here
GNRSU vs HLBBF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HLBBF has a market cap of 5.5B. Regarding current trading prices, GNRSU is priced at $0.00, while HLBBF trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HLBBF's P/E ratio is 13.53. In terms of profitability, GNRSU's ROE is +0.15%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, GNRSU and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
GNRSU vs HLUBF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, GNRSU is priced at $0.00, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HLUBF's P/E ratio is 9.45. In terms of profitability, GNRSU's ROE is +0.15%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, GNRSU is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HLUBF's competition here
GNRSU vs DNPUF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, DNPUF has a market cap of 4.8B. Regarding current trading prices, GNRSU is priced at $0.00, while DNPUF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas DNPUF's P/E ratio is 4.90. In terms of profitability, GNRSU's ROE is +0.15%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, GNRSU is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check DNPUF's competition here
GNRSU vs SMDPY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SMDPY has a market cap of 4.7B. Regarding current trading prices, GNRSU is priced at $0.00, while SMDPY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SMDPY's P/E ratio is 4.80. In terms of profitability, GNRSU's ROE is +0.15%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, GNRSU is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SMDPY's competition here
GNRSU vs SGFEF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, GNRSU is priced at $0.00, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SGFEF's P/E ratio is 20.28. In terms of profitability, GNRSU's ROE is +0.15%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, GNRSU is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SGFEF's competition here
GNRSU vs HKMPY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HKMPY has a market cap of 4.1B. Regarding current trading prices, GNRSU is priced at $0.00, while HKMPY trades at $37.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HKMPY's P/E ratio is 10.28. In terms of profitability, GNRSU's ROE is +0.15%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, GNRSU and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
GNRSU vs HKMPF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HKMPF has a market cap of 3.9B. Regarding current trading prices, GNRSU is priced at $0.00, while HKMPF trades at $18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HKMPF's P/E ratio is 10.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, GNRSU is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HKMPF's competition here
GNRSU vs APNHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, APNHF has a market cap of 3.9B. Regarding current trading prices, GNRSU is priced at $0.00, while APNHF trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas APNHF's P/E ratio is -34.76. In terms of profitability, GNRSU's ROE is +0.15%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, GNRSU is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check APNHF's competition here
GNRSU vs APNHY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, APNHY has a market cap of 3.8B. Regarding current trading prices, GNRSU is priced at $0.00, while APNHY trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas APNHY's P/E ratio is -34.52. In terms of profitability, GNRSU's ROE is +0.15%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, GNRSU and APNHY have similar daily volatility (0.00).Check APNHY's competition here
GNRSU vs LBTSF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, GNRSU is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, GNRSU's ROE is +0.15%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, GNRSU and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
GNRSU vs CHSYF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, GNRSU is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, GNRSU's ROE is +0.15%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, GNRSU is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CHSYF's competition here
GNRSU vs HYPMY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, GNRSU is priced at $0.00, while HYPMY trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HYPMY's P/E ratio is 11.97. In terms of profitability, GNRSU's ROE is +0.15%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, GNRSU is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HYPMY's competition here
GNRSU vs INVVY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GNRSU is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GNRSU's ROE is +0.15%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, GNRSU and INVVY have similar daily volatility (0.00).Check INVVY's competition here
GNRSU vs IZQVF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GNRSU is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GNRSU's ROE is +0.15%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, GNRSU and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
GNRSU vs CURLF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CURLF has a market cap of 2.5B. Regarding current trading prices, GNRSU is priced at $0.00, while CURLF trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CURLF's P/E ratio is -10.20. In terms of profitability, GNRSU's ROE is +0.15%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, GNRSU is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CURLF's competition here
GNRSU vs HMDCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, GNRSU is priced at $0.00, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, GNRSU's ROE is +0.15%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, GNRSU is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HMDCF's competition here
GNRSU vs ULIHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ULIHF has a market cap of 2.4B. Regarding current trading prices, GNRSU is priced at $0.00, while ULIHF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ULIHF's P/E ratio is 7.50. In terms of profitability, GNRSU's ROE is +0.15%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, GNRSU is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ULIHF's competition here
GNRSU vs NPPNY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, NPPNY has a market cap of 2.2B. Regarding current trading prices, GNRSU is priced at $0.00, while NPPNY trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas NPPNY's P/E ratio is 10.87. In terms of profitability, GNRSU's ROE is +0.15%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, GNRSU is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check NPPNY's competition here
GNRSU vs DMPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, GNRSU is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, GNRSU's ROE is +0.15%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, GNRSU is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check DMPHF's competition here
GNRSU vs NPNKF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, GNRSU is priced at $0.00, while NPNKF trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas NPNKF's P/E ratio is 10.57. In terms of profitability, GNRSU's ROE is +0.15%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, GNRSU is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check NPNKF's competition here
GNRSU vs HTSUF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, GNRSU is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, GNRSU's ROE is +0.15%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, GNRSU and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
GNRSU vs ARSUF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, GNRSU is priced at $0.00, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ARSUF's P/E ratio is 18.17. In terms of profitability, GNRSU's ROE is +0.15%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, GNRSU is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ARSUF's competition here
GNRSU vs DUTV Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, GNRSU is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas DUTV's P/E ratio is N/A. In terms of profitability, GNRSU's ROE is +0.15%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, GNRSU is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check DUTV's competition here
GNRSU vs TSMRF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, GNRSU is priced at $0.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, GNRSU's ROE is +0.15%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, GNRSU is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check TSMRF's competition here
GNRSU vs GTBIF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GTBIF has a market cap of 1.7B. Regarding current trading prices, GNRSU is priced at $0.00, while GTBIF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GTBIF's P/E ratio is 15.11. In terms of profitability, GNRSU's ROE is +0.15%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, GNRSU is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check GTBIF's competition here
GNRSU vs SHPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, GNRSU is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, GNRSU's ROE is +0.15%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, GNRSU and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
GNRSU vs TCNNF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TCNNF has a market cap of 1.7B. Regarding current trading prices, GNRSU is priced at $0.00, while TCNNF trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TCNNF's P/E ratio is -14.91. In terms of profitability, GNRSU's ROE is +0.15%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, GNRSU is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check TCNNF's competition here
GNRSU vs MITPF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GNRSU is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GNRSU's ROE is +0.15%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, GNRSU is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check MITPF's competition here
GNRSU vs KARBF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GNRSU is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GNRSU's ROE is +0.15%, compared to KARBF's ROE of N/A. Regarding short-term risk, GNRSU and KARBF have similar daily volatility (0.00).Check KARBF's competition here
GNRSU vs CHIZF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, GNRSU is priced at $0.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, GNRSU's ROE is +0.15%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, GNRSU and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
GNRSU vs CASBF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, GNRSU is priced at $0.00, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CASBF's P/E ratio is -38.60. In terms of profitability, GNRSU's ROE is +0.15%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, GNRSU is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CASBF's competition here
GNRSU vs SWGHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, GNRSU is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, GNRSU's ROE is +0.15%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, GNRSU and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
GNRSU vs LJUIF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, GNRSU is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, GNRSU's ROE is +0.15%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, GNRSU is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check LJUIF's competition here
GNRSU vs BIOGY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, GNRSU is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, GNRSU's ROE is +0.15%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, GNRSU and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
GNRSU vs KSPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, GNRSU is priced at $0.00, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, GNRSU's ROE is +0.15%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, GNRSU is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check KSPHF's competition here
GNRSU vs GNMLF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, GNRSU is priced at $0.00, while GNMLF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GNMLF's P/E ratio is 10.80. In terms of profitability, GNRSU's ROE is +0.15%, compared to GNMLF's ROE of +0.08%. Regarding short-term risk, GNRSU is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check GNMLF's competition here
GNRSU vs KKPCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, GNRSU is priced at $0.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, GNRSU's ROE is +0.15%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, GNRSU is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check KKPCF's competition here
GNRSU vs EVOTF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, EVOTF has a market cap of 930.6M. Regarding current trading prices, GNRSU is priced at $0.00, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas EVOTF's P/E ratio is -7.71. In terms of profitability, GNRSU's ROE is +0.15%, compared to EVOTF's ROE of -0.12%. Regarding short-term risk, GNRSU is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check EVOTF's competition here
GNRSU vs TWAPF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, GNRSU is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, GNRSU's ROE is +0.15%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, GNRSU is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check TWAPF's competition here
GNRSU vs CSWYF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, GNRSU is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, GNRSU's ROE is +0.15%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, GNRSU is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CSWYF's competition here
GNRSU vs GLASF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GLASF has a market cap of 737.3M. Regarding current trading prices, GNRSU is priced at $0.00, while GLASF trades at $9.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GLASF's P/E ratio is -17.31. In terms of profitability, GNRSU's ROE is +0.15%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, GNRSU is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check GLASF's competition here
GNRSU vs TRXPF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GNRSU is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GNRSU's ROE is +0.15%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, GNRSU and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
GNRSU vs SHEZF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, GNRSU is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, GNRSU's ROE is +0.15%, compared to SHEZF's ROE of +0.01%. Regarding short-term risk, GNRSU is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SHEZF's competition here
GNRSU vs YIHCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, GNRSU is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, GNRSU and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
GNRSU vs AIHLF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, GNRSU is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, GNRSU's ROE is +0.15%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GNRSU and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
GNRSU vs TRSSF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GNRSU is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GNRSU's ROE is +0.15%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, GNRSU is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check TRSSF's competition here
GNRSU vs AGYTF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, GNRSU is priced at $0.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, GNRSU and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
GNRSU vs PKBFF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, GNRSU is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas PKBFF's P/E ratio is N/A. In terms of profitability, GNRSU's ROE is +0.15%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GNRSU and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
GNRSU vs KHTRF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, KHTRF has a market cap of 539.2M. Regarding current trading prices, GNRSU is priced at $0.00, while KHTRF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas KHTRF's P/E ratio is -137.50. In terms of profitability, GNRSU's ROE is +0.15%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, GNRSU and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
GNRSU vs CCHWF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GNRSU is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GNRSU's ROE is +0.15%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, GNRSU is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CCHWF's competition here
GNRSU vs BOIRF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, GNRSU is priced at $0.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, GNRSU's ROE is +0.15%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, GNRSU and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
GNRSU vs VRNOF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, GNRSU is priced at $0.00, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, GNRSU's ROE is +0.15%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, GNRSU is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check VRNOF's competition here
GNRSU vs HUMDF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HUMDF has a market cap of 466.1M. Regarding current trading prices, GNRSU is priced at $0.00, while HUMDF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HUMDF's P/E ratio is 2.95. In terms of profitability, GNRSU's ROE is +0.15%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, GNRSU is less volatile compared to HUMDF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check HUMDF's competition here
GNRSU vs PEXXF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GNRSU is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GNRSU and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
GNRSU vs SWDCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, GNRSU is priced at $0.00, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SWDCF's P/E ratio is 83.33. In terms of profitability, GNRSU's ROE is +0.15%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GNRSU is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SWDCF's competition here
GNRSU vs ELTP Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ELTP has a market cap of 391.1M. Regarding current trading prices, GNRSU is priced at $0.00, while ELTP trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ELTP's P/E ratio is 9.08. In terms of profitability, GNRSU's ROE is +0.15%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, GNRSU is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ELTP's competition here
GNRSU vs CRLBF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CRLBF has a market cap of 353.5M. Regarding current trading prices, GNRSU is priced at $0.00, while CRLBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CRLBF's P/E ratio is -2.71. In terms of profitability, GNRSU's ROE is +0.15%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, GNRSU is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CRLBF's competition here
GNRSU vs CPHRF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CPHRF has a market cap of 337.1M. Regarding current trading prices, GNRSU is priced at $0.00, while CPHRF trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CPHRF's P/E ratio is 12.64. In terms of profitability, GNRSU's ROE is +0.15%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, GNRSU is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CPHRF's competition here
GNRSU vs NIKA Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, NIKA has a market cap of 316.4M. Regarding current trading prices, GNRSU is priced at $0.00, while NIKA trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas NIKA's P/E ratio is N/A. In terms of profitability, GNRSU's ROE is +0.15%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, GNRSU and NIKA have similar daily volatility (0.00).Check NIKA's competition here
GNRSU vs BHCCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, GNRSU is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, GNRSU's ROE is +0.15%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, GNRSU is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check BHCCF's competition here
GNRSU vs PLNHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GNRSU is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GNRSU's ROE is +0.15%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, GNRSU is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check PLNHF's competition here
GNRSU vs PHCUF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, GNRSU is priced at $0.00, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, GNRSU is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check PHCUF's competition here
GNRSU vs SHIEF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, SHIEF has a market cap of 179.4M. Regarding current trading prices, GNRSU is priced at $0.00, while SHIEF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas SHIEF's P/E ratio is -8.39. In terms of profitability, GNRSU's ROE is +0.15%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, GNRSU is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check SHIEF's competition here
GNRSU vs CBWTF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CBWTF has a market cap of 149.5M. Regarding current trading prices, GNRSU is priced at $0.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CBWTF's P/E ratio is 5.33. In terms of profitability, GNRSU's ROE is +0.15%, compared to CBWTF's ROE of +0.23%. Regarding short-term risk, GNRSU is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CBWTF's competition here
GNRSU vs LOVFF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, LOVFF has a market cap of 133.4M. Regarding current trading prices, GNRSU is priced at $0.00, while LOVFF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas LOVFF's P/E ratio is 16.88. In terms of profitability, GNRSU's ROE is +0.15%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, GNRSU and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
GNRSU vs COPHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, GNRSU is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas COPHF's P/E ratio is -0.02. In terms of profitability, GNRSU's ROE is +0.15%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, GNRSU is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check COPHF's competition here
GNRSU vs BIOYF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, BIOYF has a market cap of 125.9M. Regarding current trading prices, GNRSU is priced at $0.00, while BIOYF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas BIOYF's P/E ratio is 19.21. In terms of profitability, GNRSU's ROE is +0.15%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, GNRSU and BIOYF have similar daily volatility (0.00).Check BIOYF's competition here
GNRSU vs NWPN Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, GNRSU is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas NWPN's P/E ratio is -0.04. In terms of profitability, GNRSU's ROE is +0.15%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, GNRSU is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check NWPN's competition here
GNRSU vs CWBHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CWBHF has a market cap of 113.2M. Regarding current trading prices, GNRSU is priced at $0.00, while CWBHF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CWBHF's P/E ratio is -3.71. In terms of profitability, GNRSU's ROE is +0.15%, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, GNRSU is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check CWBHF's competition here
GNRSU vs LPCUF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, GNRSU is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, GNRSU's ROE is +0.15%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, GNRSU is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check LPCUF's competition here
GNRSU vs CNVCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, GNRSU is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, GNRSU and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
GNRSU vs AAWH Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, AAWH has a market cap of 108.2M. Regarding current trading prices, GNRSU is priced at $0.00, while AAWH trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas AAWH's P/E ratio is -0.92. In terms of profitability, GNRSU's ROE is +0.15%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, GNRSU is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check AAWH's competition here
GNRSU vs HLTRF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, HLTRF has a market cap of 106.3M. Regarding current trading prices, GNRSU is priced at $0.00, while HLTRF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas HLTRF's P/E ratio is -8.72. In terms of profitability, GNRSU's ROE is +0.15%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, GNRSU and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
GNRSU vs JUSHF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, JUSHF has a market cap of 101.9M. Regarding current trading prices, GNRSU is priced at $0.00, while JUSHF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas JUSHF's P/E ratio is -1.46. In terms of profitability, GNRSU's ROE is +0.15%, compared to JUSHF's ROE of +0.76%. Regarding short-term risk, GNRSU is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check JUSHF's competition here
GNRSU vs ORXOY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ORXOY has a market cap of 98.4M. Regarding current trading prices, GNRSU is priced at $0.00, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, GNRSU's ROE is +0.15%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, GNRSU and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
GNRSU vs GRUSF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GRUSF has a market cap of 95M. Regarding current trading prices, GNRSU is priced at $0.00, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GRUSF's P/E ratio is 38.00. In terms of profitability, GNRSU's ROE is +0.15%, compared to GRUSF's ROE of +0.00%. Regarding short-term risk, GNRSU is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check GRUSF's competition here
GNRSU vs MEDXF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, MEDXF has a market cap of 93.4M. Regarding current trading prices, GNRSU is priced at $0.00, while MEDXF trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas MEDXF's P/E ratio is -144.56. In terms of profitability, GNRSU's ROE is +0.15%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, GNRSU is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check MEDXF's competition here
GNRSU vs ABSCF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ABSCF has a market cap of 90.7M. Regarding current trading prices, GNRSU is priced at $0.00, while ABSCF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ABSCF's P/E ratio is -7.61. In terms of profitability, GNRSU's ROE is +0.15%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, GNRSU is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ABSCF's competition here
GNRSU vs ORXOF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, ORXOF has a market cap of 78.7M. Regarding current trading prices, GNRSU is priced at $0.00, while ORXOF trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas ORXOF's P/E ratio is -1.76. In terms of profitability, GNRSU's ROE is +0.15%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, GNRSU is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for GNRSU.Check ORXOF's competition here
GNRSU vs EOFBY Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, GNRSU is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, GNRSU's ROE is +0.15%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, GNRSU and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
GNRSU vs GDNSF Comparison April 2026
GNRSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNRSU stands at 13. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, GNRSU is priced at $0.00, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNRSU currently has a P/E ratio of 0.00, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, GNRSU's ROE is +0.15%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, GNRSU and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here